Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.
The World Health Organization’s (WHO) recommendations on the use of antenatal corticosteroids and tocolytics need to be updated in light of new, important evidence on the use of these critical interventions.
The Global Women’s and Newborn’s Health group is conducting several evidence synthesis activities to support the update of these WHO recommendations, including systematic reviews of quantitative, qualitative and health economic evidence.
When published the recommendations will become the global standard on safe and appropriate use of these interventions.
March 2021–Dec 2022
For any general enquiries relating to this project, please contact:
Principal Research Fellow; Deputy Discipline Head, International Development; Co-Head, Global Women's and Newborn's Health Group
To create and translate knowledge into better health, so no-one is left behind.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2023 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
